Morgan Stanley Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Dara Mohsenian has maintained an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) but lowered the price target from $39 to $37.
October 27, 2023 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Keurig Dr Pepper's price target has been lowered from $39 to $37 by Morgan Stanley, though the Overweight rating is maintained.
The news is directly about Keurig Dr Pepper and its rating by Morgan Stanley. While the Overweight rating suggests that the stock is expected to outperform, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100